Works matching IS 11727047 AND DT 2023 AND VI 37 AND IP 9
Results: 6
Network Meta-analysis of Different Treatments for Vestibular Migraine.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 837, doi. 10.1007/s40263-023-01037-0
- By:
- Publication type:
- Article
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 819, doi. 10.1007/s40263-023-01033-4
- By:
- Publication type:
- Article
Over the Counter Supplements for Memory: A Review of Available Evidence.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 797, doi. 10.1007/s40263-023-01031-6
- By:
- Publication type:
- Article
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 755, doi. 10.1007/s40263-023-01027-2
- By:
- Publication type:
- Article
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 781, doi. 10.1007/s40263-023-01025-4
- By:
- Publication type:
- Article
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.
- Published in:
- CNS Drugs, 2023, v. 37, n. 9, p. 733, doi. 10.1007/s40263-023-01008-5
- By:
- Publication type:
- Article